Literature DB >> 9561369

Comparative analysis of dendritic cells derived from blood monocytes or CD34+ hematopoietic progenitor cells.

G Meierhoff1, S W Krause, R Andreesen.   

Abstract

In human tissues different populations of dendritic cells (DC) emerge from hematopoietic progenitor cells (HPC) in the bone marrow, with the intermediate steps of differentiation not being completely understood. In vitro, DC can be directly obtained from HPC or from blood monocytes (MO) cultured in the presence of GM-CSF and additional cytokines. We compared the antigenic profile of DC derived from either MO or HPC and studied their capacity to stimulate naive lymphocytes (LY) in the allogeneic mixed lymphocyte reaction. Both types of DC expressed high levels of CD1a, MHC class II, CD80, CD86 and CD40 and were potent stimulators of LY proliferation. DC of HPC origin, though, induced a stronger mixed lymphocyte reaction than MO-derived DC and showed a slightly higher average expression of costimulatory antigens. Low-level expression of CD14 did not negatively correlate with DC function on DC stimulated with lipopolysaccharide and was even slightly higher expressed on DC differentiating from HPC than on DC from CD14+ MO.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9561369     DOI: 10.1016/S0171-2985(98)80074-0

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  3 in total

1.  Characterization of MAX.3 antigen, a glycoprotein expressed on mature macrophages, dendritic cells and blood platelets: identity with CD84.

Authors:  S W Krause; M Rehli; S Heinz; R Ebner; R Andreesen
Journal:  Biochem J       Date:  2000-03-15       Impact factor: 3.857

Review 2.  Dendritic cells in the host response to implanted materials.

Authors:  Benjamin G Keselowsky; Jamal S Lewis
Journal:  Semin Immunol       Date:  2017-05-07       Impact factor: 11.130

3.  Reduced virus specific T helper cell induction by autologous dendritic cells in patients with chronic hepatitis B - restoration by exogenous interleukin-12.

Authors:  H F Löhr; S Pingel; W O Böcher; H Bernhard; S Herzog-Hauff; S Rose-John; P R Galle
Journal:  Clin Exp Immunol       Date:  2002-10       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.